Revenue Growth Momentum
IEX grew total revenue by 8.9% year-over-year to $886.9M in Q1 FY2026, up from $814.3M in the prior-year period, reflecting continued demand across its business segments.
Source: 10-Q Income Statement
Computed from published fixed rules, not a model's judgement — though one input, the count of high-severity risks, comes from the AI analysis below.
Not investment advice and not a price target: it scores the quarter's fundamentals, not the stock. Full methodology →
AI Takeaway
IEX delivered strong Q1 FY2026 results with revenue up 8.9% to $886.9M, net income surging 25.7% to $120.0M, and EPS rising 27.8% to $1.61, driven by operating leverage that expanded operating margin by 200 basis points year-over-year.
Revenue
$886.9M
+8.92% YoY
EPS (Diluted)
$1.61
+27.78% YoY
Gross Margin
44.9%
-0.4 pts YoY
Operating Income
$172.4M
+21.41% YoY
Source: SEC XBRL
Idex (IEX) reported Q1 FY2026 revenue of $886.9M, up 8.9% year over year. Operating margin was 19.4%, up 2.0 points from 17.4% a year earlier. Operating cash flow was $103.7M, down 1.9% year over year. IEX's fiscal Q1 FY2026 corresponds to calendar Q1 2026.
Last 4 quarters: 4 beats
| Quarter | Actual EPS (USD) | Consensus (USD) | Result |
|---|---|---|---|
| Jun 2026 | 2.32 | 2.13 | Beat +8.9% |
| Mar 2026This filing | 2.00 | 1.79 | Beat +11.7% |
| Dec 2025 | 2.10 | 2.06 | Beat +1.8% |
| Sep 2025 | 2.03 | 1.95 | Beat +4.1% |
Adjusted (non-GAAP) EPS of $2.00 versus the $1.79 analyst consensus — a +11.7% beat for Mar 2026. Analyst consensus is quoted on the adjusted (non-GAAP) basis the street uses. GAAP diluted EPS for this quarter was $1.61.
Compiled by AI from this SEC filing
IEX grew total revenue by 8.9% year-over-year to $886.9M in Q1 FY2026, up from $814.3M in the prior-year period, reflecting continued demand across its business segments.
Source: 10-Q Income Statement
Operating income jumped 21.4% to $172.4M, with operating margin expanding approximately 200 basis points to 19.4% from 17.4%, as SG&A expense growth was contained to just 4.3% YoY ($218.3M vs. $209.4M), well below the revenue growth rate.
Source: 10-Q Income Statement
Net income grew 25.7% to $120.0M and both basic and diluted EPS rose 27.8% to $1.61, outpacing revenue growth and indicating meaningful operating and financial leverage in the business model.
Source: 10-Q Income Statement
Stockholders' equity increased 3.7% to $4.05B, long-term debt declined 3.6% to $1.88B, and current liabilities fell 13.3% to $506.0M, resulting in a strong current ratio of 3.39 and a manageable debt-to-equity ratio of 0.71.
Source: 10-Q Balance Sheet
IEX repurchased $76.3M in shares during Q1 FY2026, a 52.6% increase from $50.0M in the prior-year period, reflecting management's confidence in the company's financial position and commitment to returning capital.
Source: 10-Q Cash Flow Statement
Compiled by AI from this SEC filing · 0 high, 3 medium, 2 low
Gross margin declined slightly to 44.9% from 45.3% year-over-year, as cost of revenue grew 9.7%—faster than revenue growth of 8.9%. Sustained input cost pressures or unfavorable product mix shifts could further compress profitability if not offset by pricing or efficiency gains.
Source: 10-Q Income Statement, Key Ratios
IEX carries $1.88B in long-term debt, representing a debt-to-equity ratio of 0.71. While the ratio is manageable and debt declined 3.6% YoY, rising interest rates or a deterioration in operating cash flow could increase refinancing risk and constrain financial flexibility.
Source: 10-Q Balance Sheet
Despite strong net income growth of 25.7%, operating cash flow declined 1.9% to $103.7M, suggesting working capital headwinds or non-cash items are dampening cash conversion. A persistent gap between reported earnings and cash generation could be a concern for long-term investors.
Source: 10-Q Cash Flow Statement
Investing cash outflows more than doubled to -$20.4M from -$10.0M in the prior year, a 104% increase, indicating accelerating capital expenditure or acquisition activity. Combined with higher share buybacks of $76.3M, total cash deployment is rising while cash balances declined slightly to $586.2M.
Source: 10-Q Cash Flow Statement
Despite strong net income growth, ROE stands at only 2.96% and ROA at 1.73% on a quarterly basis, suggesting the company's large asset base ($6.92B) and equity base ($4.05B) are not yet generating proportionally high returns. Sustained improvement in capital efficiency will be key to long-term value creation.
Source: 10-Q Balance Sheet, Key Ratios
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue $M | 886.90 $M | 814.30 $M | +8.92% |
Cost of Revenue $M | 488.80 $M | 445.40 $M | +9.74% |
Gross Profit $M | 398.10 $M | 368.90 $M | +7.92% |
Operating Income $M | 172.40 $M | 142.00 $M | +21.41% |
Net Income $M | 120.00 $M | 95.50 $M | +25.65% |
EPS (Basic) $ | 1.61 $ | 1.26 $ | +27.78% |
EPS (Diluted) $ | 1.61 $ | 1.26 $ | +27.78% |
SG&A Expense $M | 218.30 $M | 209.40 $M | +4.25% |
Answers draw on this SEC filing and the data on this page
IDEX Corporation reported Q2 FY2026 revenue of $920.6M (+6.4% YoY) and diluted EPS of $1.93 (+10.9% YoY), driven by strong demand in Health & Science Technologies and net gains from IEEPA tariff refunds.
IEX Group delivered 5.8% revenue growth to $3.46B in FY2025, but net income declined 4.3% to $483.2M as SG&A expenses surged 7.9% and higher costs offset top-line gains.
Other companies in Industrial Machinery & Supplies & Components